Discover one of our 28 local entrepreneurial communities »
Be the first to know as we launch in new countries and markets around the globe.
Interested in bringing MIT Technology Review to your local market?
Unsupported browser: Your browser does not meet modern web standards. See how it scores »
Krishna Palem thinks a little uncertainty in chips could extend battery life in mobile devices–and maybe the duration of Moore’s Law, too.
A small section of protein turns out to be responsible for the infectious properties of prions.
Geron CEO Thomas B. Okarma on creating stem cell therapies.
A wobbly new molecule called DTA is moving in a straight line toward nanomanufacturing.
Handled with care, the new “HapMap” of genetic variation could reveal the genetic roots of many diseases.
New techniques for making embryonic stem cell lines may not quiet ethical debate.
Biotech drugs can cost hundreds of thousands of dollars a year. Cheaper generic versions could save countless lives, but proving their safety and effectiveness is no easy task.
Simon Barber on Europe’s reluctance to accept genetically modified foods.